HO1 plays an important role in iron metabolism alteration in breast cancer cells
; Gandini, Norberto Ariel
; Facchinetti, Maria Marta
; Curino, Alejandro Carlos
; Roque, Marta Elena Otros responsables
Fecha
2019
Editorial
Fundación Revista Medicina
Revista
TĆtulo del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación ClĆnica; LI Reunión Anual de la Asociación Argentina de FarmacologĆa Experimental; XXI Reunión Anual de la Sociedad Argentina de BiologĆa; XXXI Reunión Anual de la Sociedad Argentina de ProtozoologĆa; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión CientĆfica Regional de la Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación ClĆnica
Asociación Argentina de FarmacologĆa Experimental
Sociedad Argentina de BiologĆa
Asociación Argentina de Nanomedicinas
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
The Histochemical Society
Asociación Argentina de FarmacologĆa Experimental
Sociedad Argentina de BiologĆa
Asociación Argentina de Nanomedicinas
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y TecnologĆa de Animales de Laboratorio
The Histochemical Society
ISSN
0025-7680
eISSN
1669-9106
ISBN
Idioma
InglƩs
Tipo del evento
Reunión
Clasificación temÔtica
Palabras clave
Resumen
Heme Oxygenase-1 (HO1) catalyzes heme degradation, yielding biliverdin, carbon monoxide and iron. When iron is in excess produces oxidative stress through reactive oxygen species (ROS) generation. Since both HO1 and iron metabolism disruptions have been related to breast cancer progression, we sought to investigate how tumor cells regulate iron metabolism when HO-1 expression is altered. For this purpose, we first investigated the correlation of HO1 with several iron proteins by using in silico analyses and corroborated the strongest hits by using immunohistochemistry (IHC) performed on human biopsies (n= 33). In addition, a syngeneic model of LM3 and a xenograft model of MDA-MB-231 cells stably overexpressing HO1 were used to study these hits. We further performed in culture analyses using LM3 breast cancer cells treated with hemin (H), vehicle or the combination with an antioxidant, and studied iron storage (Prussian Blue), ROS levels (DFCA) and cell cycle progression (flow cytometry). In silico analyses showed that HO1 correlated with DMT1 (p= 9.8e-05), ZIP14 (p= 4.2e-06), Prohepcidin (p= 1.4e-12) and L-ferritin (p= 2.2e-16). In order to study the correlation between HO1 and DMT1 in breast cancer we analyzed by IHC their expression in biopsies. We observed an inverse correlation between DMT1 and HO1 expression (p<0.05). The IHC studies showed an increase in ZIP14 and prohepcidin expression and a slight decrease in L- ferritin and DMT1 expression in hemin-treated and HO1- overexpressing cells in both animal models. In culture studies showed that the iron storage was increased in hemin- treated LM3 cells and was associated to a decrease in cell viability (p<0.05), an increase in the apoptotic rate (p<0.05) and high ROS levels (p<0.01). NAC treatment reverted the apoptotic effect of H (p<0.05). Altogether these results indicate that HO1 induction plays a role in carcinogenesis through free iron accumulation, ROS production and oxidative stress.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este Ćtem se describe como by-nc-sa
